Citigroup
NRXS icon

Citigroup’s Neuraxis NRXS Stock Holding History

Citigroup’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-302
Closed -$930 – 6333
2025
Q3 		$930 Buy
+302
New +$769 ﹤0.01% 5634

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $142M AUM 161.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's NRXS Position: Q4 2025 in Review

Citigroup sold out of Neuraxis (NRXS) in Q4 2025, closing a stake of 302 shares — an estimated $930 sold.

Citigroup first reported a position in NRXS in Q3 2025 and held it in 1 quarter. The position peaked at $930 in Q3 2025. 18 funds tracked by Wall St. Rank hold NRXS as of Q4 2025.

  • Citigroup reported no remaining Neuraxis position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 302 Neuraxis shares in Q4 2025, an estimated $930.
  • Citigroup first reported a position in Neuraxis in Q3 2025 and held it in 1 quarter.
  • Citigroup's Neuraxis position peaked at $930 in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Neuraxis as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.